Markus Vogt

3.5k total citations
32 papers, 2.7k citations indexed

About

Markus Vogt is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Markus Vogt has authored 32 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Virology and 6 papers in Infectious Diseases. Recurrent topics in Markus Vogt's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (6 papers) and Photoreceptor and optogenetics research (3 papers). Markus Vogt is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (6 papers) and Photoreceptor and optogenetics research (3 papers). Markus Vogt collaborates with scholars based in Germany, Switzerland and United States. Markus Vogt's co-authors include Klaus Schulze‐Osthoff, Sebastian Wesselborg, Martin Hirsch, M. Lienhard Schmitz, Manuel Bauer, Kevan L. Hartshorn, Wulf Dröge, Ting‐Chao Chou, Robert T. Schooley and Heike Schenk and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Markus Vogt

30 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Vogt Germany 19 1.2k 616 588 583 524 32 2.7k
Margarita Hadzopoulou‐Cladaras United States 27 2.0k 1.7× 590 1.0× 357 0.6× 304 0.5× 472 0.9× 41 3.4k
Tong Zhang China 31 1.2k 1.0× 701 1.1× 1.5k 2.6× 519 0.9× 433 0.8× 148 3.7k
Yuji Iizawa Japan 23 700 0.6× 652 1.1× 1.2k 2.0× 621 1.1× 145 0.3× 46 2.8k
Étienne Jacotot France 18 3.7k 3.1× 565 0.9× 863 1.5× 327 0.6× 372 0.7× 22 5.1k
Gabriele Sass United States 32 1.5k 1.3× 184 0.3× 505 0.9× 437 0.7× 222 0.4× 88 3.0k
Yoshio Inagaki Japan 13 901 0.8× 255 0.4× 823 1.4× 253 0.4× 174 0.3× 20 2.5k
Anne Roulston Canada 24 1.9k 1.6× 242 0.4× 1.1k 2.0× 288 0.5× 674 1.3× 42 3.5k
Markus Loeffler Germany 15 4.0k 3.4× 342 0.6× 840 1.4× 264 0.5× 403 0.8× 24 5.4k
Yuan Lin China 29 1.9k 1.6× 132 0.2× 539 0.9× 287 0.5× 285 0.5× 140 3.4k
Nicholas Murgolo United States 30 1.8k 1.5× 125 0.2× 507 0.9× 567 1.0× 314 0.6× 64 4.3k

Countries citing papers authored by Markus Vogt

Since Specialization
Citations

This map shows the geographic impact of Markus Vogt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Vogt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Vogt more than expected).

Fields of papers citing papers by Markus Vogt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Vogt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Vogt. The network helps show where Markus Vogt may publish in the future.

Co-authorship network of co-authors of Markus Vogt

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Vogt. A scholar is included among the top collaborators of Markus Vogt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Vogt. Markus Vogt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vogt, Markus, et al.. (2025). Direct Stimulation of Gastric Smooth Muscle Cells via Gq Proteins With Light. Neurogastroenterology & Motility. 37(6). e70028–e70028. 1 indexed citations
2.
Malan, Daniela, Markus Vogt, Thomas Beiert, et al.. (2022). Selective optogenetic control of Gq signaling using human Neuropsin. Nature Communications. 13(1). 1765–1765. 27 indexed citations
3.
Osinga, Rik, Michael Baumberger, Jörg Krebs, et al.. (2022). Osteomyelitis and antibiotic treatment in patients with grade IV pressure injury and spinal cord lesion—a retrospective cohort study. Spinal Cord. 60(6). 540–547. 9 indexed citations
4.
Vogt, Markus, Benjamin Schulz, Gijsbert J. van Belle, et al.. (2021). Direct optogenetic stimulation of smooth muscle cells to control gastric contractility. Theranostics. 11(11). 5569–5584. 18 indexed citations
5.
Adhikari, Bikash, Julia Hofstetter, Martin Schröder, et al.. (2020). PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. Nature Chemical Biology. 16(11). 1179–1188. 111 indexed citations
6.
Vogt, Markus. (2016). Die Freiheit der Verantwortung. 1 indexed citations
7.
Vogt, Markus, et al.. (2006). Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein. Oncogene. 25(29). 4009–4015. 54 indexed citations
8.
Vogt, Markus. (2003). Diagnosis and treatment of bites by cats, dogsand humans. DMW - Deutsche Medizinische Wochenschrift. 128(19). 1059–1063. 2 indexed citations
9.
Vogt, Markus, et al.. (1998). Oxidative stress and hypoxia/reoxygenation trigger CD95 (APO‐1/Fas) ligand expression in microglial cells. FEBS Letters. 429(1). 67–72. 120 indexed citations
10.
Bauer, Manuel, Markus Vogt, Marek Łoś, et al.. (1998). Role of Reactive Oxygen Intermediates in Activation-induced CD95 (APO-1/Fas) Ligand Expression. Journal of Biological Chemistry. 273(14). 8048–8055. 161 indexed citations
11.
Hehner, Steffen P., Michael Heinrich, Peter M. Bork, et al.. (1998). Sesquiterpene Lactones Specifically Inhibit Activation of NF-κB by Preventing the Degradation of IκB-α and IκB-β. Journal of Biological Chemistry. 273(3). 1288–1297. 310 indexed citations
12.
Wesselborg, Sebastian, Manuel Bauer, Markus Vogt, M. Lienhard Schmitz, & Klaus Schulze‐Osthoff. (1997). Activation of Transcription Factor NF-κB and p38 Mitogen-activated Protein Kinase Is Mediated by Distinct and Separate Stress Effector Pathways. Journal of Biological Chemistry. 272(19). 12422–12429. 220 indexed citations
13.
Pahl, Heike L., Klaus Schulze‐Osthoff, Tim-Michael Decker, et al.. (1996). The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB.. The Journal of Experimental Medicine. 183(4). 1829–1840. 283 indexed citations
14.
Schenk, Heike, Markus Vogt, Wulf Dröge, & Klaus Schulze‐Osthoff. (1996). Thioredoxin as a potent costimulus of cytokine expression. The Journal of Immunology. 156(2). 765–771. 140 indexed citations
16.
Hartmann, Heinz, et al.. (1988). Enhanced In Vitro Inhibition of HIV-1 Replication by 3′-Fluoro-3′-deoxythymidine Compared to Several Other Nucleoside Analogs. AIDS Research and Human Retroviruses. 4(6). 457–466. 56 indexed citations
17.
Hartshorn, Kevan L., et al.. (1987). Activity of Interferons Alpha, Beta, and Gamma Against Human Immunodeficiency Virus Replication In Vitro. AIDS Research and Human Retroviruses. 3(2). 125–133. 107 indexed citations
18.
Vogt, Markus & Martin Hirsch. (1987). Treatment of Human Immunodeficiency Virus Infections. Infectious Disease Clinics of North America. 1(2). 323–340. 11 indexed citations
19.
Kleihues, Paul, W. Lang, P. C. Burger, et al.. (1985). Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS). Acta Neuropathologica. 68(4). 333–339. 110 indexed citations
20.
Vogt, Markus, et al.. (1980). [Decompensated liver cirrhosis caused by galactosemia in a 52-year-old man].. PubMed. 110(47). 1781–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026